SEARCH

SEARCH BY CITATION

References

  • 1
    Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:25602572.
  • 2
    Sica DA. Edema mechanisms in the heart failure patient and treatment options. Heart Fail Clin. 2008;4:511518.
  • 3
    Beerman B, Groschinsky-Grind M. Pharmacokinetics of hydrochlorothiazide in patients with congestive heart failure. Br J Clin Pharmacol. 1979;7:579583.
  • 4
    Sica DA. Chlorthalidone: has it always been the best thiazide-type diuretic? Hypertension. 2006;47:321322.
  • 5
    Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension. 2004;43:49.
  • 6
    Murray MD, Haag KM, Black PK, et al. Variable furosemide absorption and poor predictability of response in elderly patients. Pharmacotherapy. 1997;17:98106.
  • 7
    Vargo DL, Kramer WG, Black PK, et al. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure. Clin Pharmacol Ther. 1995;57:601609.
  • 8
    Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Engl J Med. 1993;328:914921.
  • 9
    Ernst ME, Carter BL, Goerdt CJ, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension. 2006;47:352358.
  • 10
    Holland OB, Gomez-Sanchez CE, Kuhnert LV, et al. Antihypertensive comparison of furosemide with hydrochlorothiazide for black patients. Arch Intern Med. 1979;139:10151021.
  • 11
    K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(supp 1):S1290.
  • 12
    Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressure averaging 115 through 129 mm Hg. JAMA. 1967;202:10281034.
  • 13
    Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA. 1970;213:11431152.
  • 14
    Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the systolic hypertension in the elderly program (SHEP). SHEP cooperative research group. JAMA. 1991;265:32553264.
  • 15
    Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2002;288:29812997.
  • 16
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Diuretic versus alpha-blocker as first-step antihypertensive therapy. Final results from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Hypertension. 2003;42:239246.
  • 17
    Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA. 1997;277:739745.
  • 18
    Wright JM, Musini VM. First-line drugs for hypertension. Cochrane Database Syst Rev. 2009;3:CD001841.
  • 19
    Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:24172428.
  • 20
    Materson BJ, Cushman WC, Goldstein G, et al. for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Treatment of hypertension in the elderly. I. Blood pressure and clinical changes. Results of a department of veterans affairs cooperative study. Hypertension. 1990;15:348360.
  • 21
    Kaplan NM, Carnegie A, Raskin P, et al. Potassium supplementation in hypertensive patients with diuretic-induced hypokalemia. N Engl J Med. 1985;312:746749.
  • 22
    Materson BJ, Reda DJ, Cushman WC, et al. for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Results of combination antihypertensive therapy after failure of each of the components. J Hum Hypertens. 1995;9:791796.
  • 23
    Sica DA. Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats. Drugs. 2002;62:443462.
  • 24
    Ernst ME, Carter BL, Zheng S, et al. Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium. Am J Hypertens. 2010; 23:440446.
  • 25
    Zillich AJ, Garg J, Basu S, et al. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension. 2006;48:219224.
  • 26
    Hunter DJ, York M, Chaisson CE, et al. Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study. J Rheumatol. 2006;33:13411345.
  • 27
    Juurlink DN, Mamdani MM, Kopp A. Drug-induced lithium toxicity in the elderly: a population-based study. J Am Geriatr Soc. 2004; 52:794798.